(Total Views: 443)
Posted On: 04/15/2019 11:50:32 AM
Post# of 72436
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
We may hear something tomorrow or maybe after hours today...
From the EMA Website.
"For the Committee for Medicinal Products for Human Use (CHMP) and the Pharmacovigilance Risk Assessment Committee (PRAC), EMA publishes meeting highlights to communicate information of major public interest, usually the day after their meetings have ended.
As a matter of good practice, marketing authorisation holders, applicants and third parties should wait until EMA communication is published before publishing their own communication related to the committee's outcome."
From the EMA Website.
"For the Committee for Medicinal Products for Human Use (CHMP) and the Pharmacovigilance Risk Assessment Committee (PRAC), EMA publishes meeting highlights to communicate information of major public interest, usually the day after their meetings have ended.
As a matter of good practice, marketing authorisation holders, applicants and third parties should wait until EMA communication is published before publishing their own communication related to the committee's outcome."
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)